ES2061708T3 - Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus. - Google Patents
Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus.Info
- Publication number
- ES2061708T3 ES2061708T3 ES88402695T ES88402695T ES2061708T3 ES 2061708 T3 ES2061708 T3 ES 2061708T3 ES 88402695 T ES88402695 T ES 88402695T ES 88402695 T ES88402695 T ES 88402695T ES 2061708 T3 ES2061708 T3 ES 2061708T3
- Authority
- ES
- Spain
- Prior art keywords
- virus
- gallina
- smallpox
- vaccines
- vectors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000700605 Viruses Species 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000700647 Variola virus Species 0.000 title 1
- 244000144977 poultry Species 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
- 108091029795 Intergenic region Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
VIRUS DEL FENULPOX RECOMBINANTE, DERIVADO DE UNA CAPA ATENUADA, TENIENDO INTEGRADA EN UNA REGION INTERGENICA NO CODIFICANTE DE SU GENOMA UNA SECUENCIA DE ADN CODIFICANTE PARA UNA PROTEINA HETEROLOGA. VACUNA CON ESTE VIRUS DEL FONULPLAX RECOMBINANTE EXPRIMIENDO UN ANTIGENO DE UN VIRUS HETEROLOGO.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8715001A FR2622456B1 (fr) | 1987-10-29 | 1987-10-29 | Virus du fowlpox recombinant, vecteurs d'expression de proteines heterologues et vaccins pour la volaille derives de ce virus |
FR888808226A FR2632863B2 (fr) | 1987-10-29 | 1988-06-20 | Virus du fowlpox recombinant et vaccins derives de ces virus |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2061708T3 true ES2061708T3 (es) | 1994-12-16 |
Family
ID=26226297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88402695T Expired - Lifetime ES2061708T3 (es) | 1987-10-29 | 1988-10-26 | Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5180675A (es) |
EP (1) | EP0314569B1 (es) |
JP (1) | JP2766984B2 (es) |
AU (1) | AU633472B2 (es) |
CA (1) | CA1341263C (es) |
DE (1) | DE3888086T2 (es) |
DK (1) | DK175291B1 (es) |
ES (1) | ES2061708T3 (es) |
FR (1) | FR2632863B2 (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
US7767449B1 (en) | 1981-12-24 | 2010-08-03 | Health Research Incorporated | Methods using modified vaccinia virus |
US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
DE10399032I1 (de) * | 1987-08-28 | 2004-01-29 | Health Research Inc | Rekombinante Viren. |
JP2779447B2 (ja) * | 1988-03-20 | 1998-07-23 | 財団法人阪大微生物病研究会 | 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体 |
US5631154A (en) * | 1988-06-10 | 1997-05-20 | Therion Biologics, Incorporated | Self assembled, defective, non-self-propagating lentivirus particles |
EP0353851B1 (en) * | 1988-06-24 | 1994-01-19 | Btg International Limited | Fowlpox virus non-essential regions |
US5093258A (en) * | 1988-08-26 | 1992-03-03 | Therion Biologics Corporation | Recombinant fowlpox virus and recombination vector |
JP2781605B2 (ja) * | 1989-06-22 | 1998-07-30 | 日本ゼオン株式会社 | 組み換えアビポックスウイルス |
US5503834A (en) * | 1990-11-20 | 1996-04-02 | Virogenetics Corporation | Measles virus recombinant poxvirus vaccine |
US6309647B1 (en) | 1999-07-15 | 2001-10-30 | Aventis Pasteur | Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants |
US5759841A (en) * | 1990-11-20 | 1998-06-02 | Virogenetics Corporation | Immunological composition of measles virus utilizing recombinant poxvirus |
IE68404B1 (en) * | 1990-11-20 | 1996-06-12 | Virogenetics Corp | Measles virus recombinant poxvirus vaccine |
AU699903B2 (en) * | 1990-11-20 | 1998-12-17 | Virogenetics Corporation | Measles virus recombinant poxvirus vaccine |
US5756102A (en) * | 1990-11-20 | 1998-05-26 | Virogenetics Corporation | Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants |
JP3602530B2 (ja) * | 1991-03-07 | 2004-12-15 | ヴァイロジェネティクス コーポレイション | 遺伝子操作したワクチン菌株 |
US5766598A (en) * | 1991-03-07 | 1998-06-16 | Virogenetics Corporation | Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products |
US5641490A (en) * | 1991-03-07 | 1997-06-24 | Virogenetics Corporation | Infectious bursal disease virus recombinant poxvirus vaccine |
US5759552A (en) * | 1991-03-07 | 1998-06-02 | Virogenetics Corporation | Marek's disease virus recombinant poxvirus vaccine |
BE1004877A3 (fr) * | 1991-05-27 | 1993-02-16 | Solvay | Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus. |
US5369025A (en) * | 1991-06-28 | 1994-11-29 | The United States Of America As Represented By The Secretary Of Agriculture | Recombinant fowlpox vaccine for protection against Marek's disease |
EP0538496B1 (en) * | 1991-08-26 | 2003-10-29 | Baxter Healthcare S.A. | Recombinant fowlpox virus with intact FPV-tk-gene |
AU680609B2 (en) * | 1992-01-13 | 1997-08-07 | Virogenetics Corporation | Marek's disease virus recombinant poxvirus vaccine |
US6136318A (en) * | 1993-02-26 | 2000-10-24 | Cochran; Mark D. | Recombinant fowlpox viruses and uses thereof |
AU727278B2 (en) * | 1993-02-26 | 2000-12-07 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof II |
US5925358A (en) * | 1993-02-26 | 1999-07-20 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof |
EP0696204A4 (en) * | 1993-02-26 | 1999-03-31 | Syntro Corp | Recombined chickenpox virus and its use |
EP0832197A4 (en) * | 1995-06-07 | 2002-10-16 | Syntro Corp | RECOMBINANT AVIAN SMALLPOX VIRUS AND USES THEREOF |
DK0775746T3 (da) | 1995-07-03 | 2006-04-03 | Akzo Nobel Nv | Vaccine mod fjerkræcoccidiose |
EP1601333B1 (en) * | 2003-02-20 | 2013-01-23 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services | Novel insertion sites in pox vectors |
JP4842128B2 (ja) | 2003-07-21 | 2011-12-21 | トランジェーヌ、ソシエテ、アノニム | 新規多機能性サイトカイン |
MX2009008118A (es) | 2007-01-30 | 2009-10-13 | Transgene Sa | Polipeptido e2 del virus del papiloma usado para vacunacion. |
DK2382474T3 (en) | 2009-01-20 | 2015-04-07 | Transgene Sa | SOLUBLE ICAM-1 as a biomarker FOR PREDICTION OF THERAPEUTIC RESPONSE |
NZ595290A (en) | 2009-03-24 | 2012-09-28 | Transgene Sa | Biomarker for monitoring patients |
CN102395883B (zh) | 2009-04-17 | 2015-12-02 | 特朗斯吉有限公司 | 用于监控患者的生物标志物 |
CA2767458A1 (en) | 2009-07-10 | 2011-01-13 | Bruce Acres | Biomarker for selecting patients and related methods |
RU2493253C1 (ru) * | 2012-04-25 | 2013-09-20 | Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") | АТТЕНУИРОВАННЫЙ ШТАММ "КЭМ-7" ВИРУСА ОСПЫ КУР Fowlpox virus ДЛЯ ИЗГОТОВЛЕНИЯ ПРЕПАРАТОВ СПЕЦИФИЧЕСКОЙ ПРОФИЛАКТИКИ И ДИАГНОСТИКИ ОСПЫ ПТИЦ |
EP3587455A1 (en) | 2012-10-23 | 2020-01-01 | Emory University | Gm-csf and il-4 conjugates, compositions, and methods related thereto |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3429965A (en) * | 1966-08-01 | 1969-02-25 | Sterling Drug Inc | Avian pox virus vaccine and process of preparing same |
US4603112A (en) * | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
FR2563434B1 (fr) * | 1984-04-25 | 1986-07-25 | Transgene Sa | Vaccin contre la rage et procede pour sa preparation |
WO1986000528A1 (en) * | 1984-07-05 | 1986-01-30 | Genex Corporation | Cloned gene and method for making and using the same |
WO1986005806A1 (en) * | 1985-03-29 | 1986-10-09 | National Research Development Corporation | Infectious bronchitis virus spike protein |
FR2583429B1 (fr) * | 1985-06-18 | 1989-11-03 | Transgene Sa | Vecteur d'expression de l'interferon u dans les cellules de mammifere, procede pour sa mise en oeuvre et produit obtenu et composition pharmaceutique contenant l'interferon u |
AU602875B2 (en) * | 1985-12-18 | 1990-11-01 | British Technology Group Limited | Newcastle disease virus gene clones |
EP0257994B1 (en) * | 1986-08-29 | 1992-09-16 | Tonen Corporation | Dna coding for rinderpest virus antigen, its preparation and use |
AU8075787A (en) * | 1986-09-22 | 1988-04-07 | Australian National University, The | Recombinant poxviruses |
WO1988002022A1 (en) * | 1986-09-22 | 1988-03-24 | Commonwealth Scientific And Industrial Research Or | Recombinant poxviruses |
DE3853088T2 (de) * | 1987-03-27 | 1995-10-19 | Nippon Zeon Co | Rekombinantes Avipoxvirus. |
JPH03503482A (ja) * | 1988-02-12 | 1991-08-08 | コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガナイゼーション | ポックスウイルスベクター |
DE3813093A1 (de) * | 1988-04-19 | 1989-11-09 | Immuno Ag | Rekombinantes plasmid, verfahren zum herstellen eines rekombinanten avipoxvirus, rekombinantes avipoxvirus und dessen verwendung |
EP0353851B1 (en) * | 1988-06-24 | 1994-01-19 | Btg International Limited | Fowlpox virus non-essential regions |
US5093258A (en) * | 1988-08-26 | 1992-03-03 | Therion Biologics Corporation | Recombinant fowlpox virus and recombination vector |
-
1988
- 1988-06-20 FR FR888808226A patent/FR2632863B2/fr not_active Expired - Lifetime
- 1988-10-26 ES ES88402695T patent/ES2061708T3/es not_active Expired - Lifetime
- 1988-10-26 DE DE3888086T patent/DE3888086T2/de not_active Expired - Fee Related
- 1988-10-26 EP EP88402695A patent/EP0314569B1/fr not_active Expired - Lifetime
- 1988-10-27 JP JP63272864A patent/JP2766984B2/ja not_active Expired - Fee Related
- 1988-10-28 AU AU24458/88A patent/AU633472B2/en not_active Ceased
- 1988-10-28 CA CA000581654A patent/CA1341263C/fr not_active Expired - Fee Related
- 1988-10-28 DK DK198806038A patent/DK175291B1/da not_active IP Right Cessation
- 1988-10-28 US US07/264,493 patent/US5180675A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5180675A (en) | 1993-01-19 |
AU2445888A (en) | 1989-05-04 |
DK603888D0 (da) | 1988-10-28 |
AU633472B2 (en) | 1993-02-04 |
DK175291B1 (da) | 2004-08-09 |
JPH02430A (ja) | 1990-01-05 |
JP2766984B2 (ja) | 1998-06-18 |
EP0314569A1 (fr) | 1989-05-03 |
FR2632863A2 (fr) | 1989-12-22 |
DE3888086D1 (de) | 1994-04-07 |
DE3888086T2 (de) | 1994-10-06 |
EP0314569B1 (fr) | 1994-03-02 |
CA1341263C (fr) | 2001-06-26 |
FR2632863B2 (fr) | 1990-08-31 |
DK603888A (da) | 1989-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2061708T3 (es) | Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus. | |
ES8500322A1 (es) | Un metodo de modificar un virus para conferirle una nueva funcion biologica. | |
DE3853088T2 (de) | Rekombinantes Avipoxvirus. | |
DE69133228T2 (de) | Dna-expressionssysteme basierend auf alphaviren | |
DE58906121D1 (de) | Rekombinantes Vaccinia-Virus MVA. | |
DE3583293D1 (de) | Lymphadenopathie-assoziierte huellenantigene und deren verwendungen. | |
ES2061500T3 (es) | Diagnosis y vacunas de la hepatitis delta su preparacion y uso. | |
ES2002490A6 (es) | Un metodo de preparar un virus recombinante | |
ES2045475T3 (es) | Rna del genoma del virus de la hepatitis no-a, no-b, cdna y proteina del antigeno del virus. | |
DE69535359D1 (de) | Rekombinantes herpesvirus aus trufhähnen und seine verwendungen | |
MX9202512A (es) | Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus. | |
NO912825L (no) | Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper. | |
ATE118822T1 (de) | Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung. | |
DE69433007D1 (de) | Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus | |
ITMI913092A1 (it) | Vaccino di poxvirus ricombinante del virus del morbillo | |
TW377373B (en) | Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease | |
DE69230671T2 (de) | Impfstoffe gegen actinobacillus pleuropneumonie | |
EP0236977A3 (en) | Bovine virus diarrhea and hog cholera vaccines | |
NO964874L (no) | Fusjonsglykoprotein fra HCMV og HSV | |
IT1249684B (it) | Epitopi della proteina env del virus dell'epatite c. | |
DK498387A (da) | Virus-dna-sekvens | |
ES2062990T3 (es) | Vacunas, que contienen la proteina f del virus del sida. | |
BR9508645A (pt) | Vacina da peritonite infecciosa felina | |
ATE102252T1 (de) | Rekombinantes gefluegelpockenvirus, expressionsvektoren fuer heterologische proteine und davon derivierte gefluegelvakzine. | |
DE69028658D1 (de) | Proteine, Vakzine und Nucleinsäuren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 314569 Country of ref document: ES |